Karl Deres
Venture Partner @ BioMedPartners
Karl Deres is a startup investor at BioMedPartners. Dr. Deres is a biochemist with a strong background in the pharmaceutical industry as well as broad operational expertise and experience in the biotech sector. Dr. Deres worked for more than 15 years for Bayer Schering Pharma and Intervet Schering Plough. In 2007, he founded DPC Pharma Consulting, an advisory company offering services in thepharmaceutical/biotech industry, including interim management in the fields of business & strategic corporate development, clinical & regulatory aspects as well as R&D management. Dr. Deres supports the representation office in Munich.
Last updated:
For AI agents: llms.txt
About BioMedPartners
BioMedPartners is one of the leading European venture capital firms providing private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. They target the entire industry with special focus on pharmaceuticals, biotechnology, diagnostics and medical technology.
BioMedPartners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Fiona Lauscher
Office Manager
|
|||
|
Karl Deres
Venture Partner
|
|||
Markus Hosang
General Partner
|
|||
Patrick Burgermeister
Partner
|
|||
Stefan Fäs
Chief Financial Officer & Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
FAQ
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
